Adani Enterp. 2433.65↓-0.30(-0.01%)
Adani Ports 745.40↑6.60(0.89%)
Apollo Hospitals 4940.10↓-10.10(-0.20%)
Asian Paints 3212.75↑13.00(0.41%)
Axis Bank 968.20↑17.35(1.82%)
B P C L 356.15↓-0.65(-0.18%)
Bajaj Auto 4726.25↑16.20(0.34%)
Bajaj Finance 7113.95↑70.75(1.00%)
Bajaj Finserv 1475.10↑16.20(1.11%)
Bharti Airtel 829.45↓-5.05(-0.61%)
Britannia Inds. 4705.40↑22.80(0.49%)
Cipla 972.05↓-2.75(-0.28%)
Coal India 227.80↓-1.90(-0.83%)
Divi's Lab. 3537.90↑75.60(2.18%)
Dr Reddy's Labs 4636.65↑33.10(0.72%)
Eicher Motors 3705.10↑31.85(0.87%)
Grasim Inds 1766.40↑31.90(1.84%)
H D F C 2635.35↓-9.45(-0.36%)
HCL Technologies 1128.60↓-9.70(-0.85%)
HDFC Bank 1599.40↓-5.00(-0.31%)
HDFC Life Insur. 579.70↑5.55(0.97%)
Hero Motocorp 2904.80↑34.20(1.19%)
Hind. Unilever 2691.15↓-4.65(-0.17%)
Hindalco Inds. 415.55↓-4.15(-0.99%)
ICICI Bank 942.10↓-4.65(-0.49%)
IndusInd Bank 1306.00↑4.20(0.32%)
Infosys 1279.00↓-25.50(-1.95%)
ITC 442.80↑2.15(0.49%)
JSW Steel 712.85↑0.70(0.10%)
Kotak Mah. Bank 1959.05↑34.15(1.77%)
Larsen & Toubro 2277.95↑9.65(0.43%)
M & M 1411.20↑15.80(1.13%)
Maruti Suzuki 9736.20↑154.10(1.61%)
Nestle India 21705.40↓-128.75(-0.59%)
NTPC 175.40↑1.30(0.75%)
O N G C 153.65↓-1.75(-1.13%)
Power Grid Corpn 235.30↓-0.30(-0.13%)
Reliance Industr 2479.35↑2.10(0.08%)
SBI Life Insuran 1223.00↑7.60(0.63%)
St Bk of India 585.35↓-1.85(-0.32%)
Sun Pharma.Inds. 1013.80↑5.05(0.50%)
Tata Consumer 792.10↓-0.35(-0.04%)
Tata Motors 555.75↑9.50(1.74%)
Tata Steel 109.00↓-0.40(-0.37%)
TCS 3232.30↓-56.60(-1.72%)
Tech Mahindra 1086.25↓-23.10(-2.08%)
Titan Company 2881.45↑25.75(0.90%)
UltraTech Cem. 8109.55↑227.55(2.89%)
UPL 694.00↑4.00(0.58%)
Wipro 399.95↓-4.25(-1.05%)

Covid-19: Vaccine production is not a problem for India, cold chain is

As India prepares a road map for a Covid-19 vaccination drive next year, the lack of cold chain infrastructure is a key bottleneck

Coronavirus, vaccine, covid, drugs, clinical trials

Premium

4 min read Last Updated : Nov 17 2020 | 12:35 AM IST

India is likely to start vaccination drive around January 2021 and is now preparing the road map for what will be perhaps the world's largest vaccination drive next year. Data shows that India has ample manufacturing capacity (about 2.5 bn doses) that would be sufficient to meet both domestic and export demand, however, analysts point out that cold chain infrastructure is a key bottleneck.

According to Credit Suisse analysts India would need about 1.7 bn Covid-19 vaccine doses to vaccinate a majority of its adult population. The target is to administer 500 mn doses (or 250 mn people) by July next year. The key vaccines the country is banking on are from AstraZeneca, Novavax and Bharat Biotech and the earliest efficacy data is not expected before November-December 2020.

As for the cold chain infrastructure, India's current immunisation programme handles around 600 mn doses and the private sector has a capacity of about 250-300 mn doses.